These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 21255143)
1. Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Farahi N; Uller L; Juss JK; Langton AJ; Cowburn AS; Gibson A; Foster MR; Farrow SN; Marco-Casanova P; Sobolewski A; Condliffe AM; Chilvers ER Clin Exp Allergy; 2011 May; 41(5):673-87. PubMed ID: 21255143 [TBL] [Abstract][Full Text] [Related]
2. The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. Duffin R; Leitch AE; Sheldrake TA; Hallett JM; Meyer C; Fox S; Alessandri AL; Martin MC; Brady HJ; Teixeira MM; Dransfield I; Haslett C; Rossi AG FEBS Lett; 2009 Aug; 583(15):2540-6. PubMed ID: 19616548 [TBL] [Abstract][Full Text] [Related]
3. The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis. Leitch AE; Riley NA; Sheldrake TA; Festa M; Fox S; Duffin R; Haslett C; Rossi AG Eur J Immunol; 2010 Apr; 40(4):1127-38. PubMed ID: 20127676 [TBL] [Abstract][Full Text] [Related]
4. Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation. Alessandri AL; Duffin R; Leitch AE; Lucas CD; Sheldrake TA; Dorward DA; Hirani N; Pinho V; de Sousa LP; Teixeira MM; Lyons JF; Haslett C; Rossi AG PLoS One; 2011; 6(9):e25683. PubMed ID: 21984938 [TBL] [Abstract][Full Text] [Related]
5. Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Uller L; Rydell-Törmänen K; Persson CG; Erjefält JS Respir Res; 2005 Aug; 6(1):90. PubMed ID: 16086832 [TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Rossi AG; Sawatzky DA; Walker A; Ward C; Sheldrake TA; Riley NA; Caldicott A; Martinez-Losa M; Walker TR; Duffin R; Gray M; Crescenzi E; Martin MC; Brady HJ; Savill JS; Dransfield I; Haslett C Nat Med; 2006 Sep; 12(9):1056-64. PubMed ID: 16951685 [TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase inhibition reduces lung damage in a mouse model of ventilator-induced lung injury. Hoogendijk AJ; Kuipers MT; van der Poll T; Schultz MJ; Wieland CW Shock; 2012 Oct; 38(4):375-80. PubMed ID: 22777120 [TBL] [Abstract][Full Text] [Related]
8. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471 [TBL] [Abstract][Full Text] [Related]
9. [Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine]. Gao JX; Zhou YQ; Zhang RH; Ma XL; Liu KJ Sheng Li Xue Bao; 2005 Dec; 57(6):755-60. PubMed ID: 16344902 [TBL] [Abstract][Full Text] [Related]
11. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro. Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Leitch AE; Lucas CD; Marwick JA; Duffin R; Haslett C; Rossi AG Cell Death Differ; 2012 Dec; 19(12):1950-61. PubMed ID: 22743999 [TBL] [Abstract][Full Text] [Related]